Radiation Detection Company Launches Radiant Real-Time Dosimetry Solution to Enhance Radiation Safety in Medical Settings Radiation Detection Company (RDC), a long-established provider of occupational radiation dosimetry services, has announced the launch of Radiant, a real-time electronic dosimetry solution designed to…
Enhertu Demonstrates Significant Progression-Free Survival Benefit in First-Line HER2 Mutant Metastatic NSCLC Daiichi Sankyo and AstraZeneca have announced positive topline results from the Phase 3 DESTINY-Lung04 trial, demonstrating that Enhertu® (trastuzumab deruxtecan) significantly improved progression-free survival (PFS) compared with the…
EMA Validates Pfizer and Valneva’s Marketing Authorization Application for Lyme Disease Vaccine Candidate Pfizer Inc.and Valneva SE have announced an important regulatory milestone for their investigational Lyme disease vaccine candidate, PF-07307405, after the European Medicines Agency (EMA) validated the companies’…
biomodal Launches duet mosaic Workflows to Unlock More Biological Signals from Every Liquid Biopsy Sample biomodal, an omics-focused life sciences technology and analytics company, has announced the launch of its new duet mosaic family, a portfolio designed to help researchers…
LeAnn Rimes to Join Next Health Longevity Summit in Nashville, Bringing Personal Perspective to the Future of Health Optimization With just one month remaining until the inaugural Next Health Longevity Summit, Next Health, a global leader in health optimization and…
GeneDx Launches Online Exome Testing Offering to Expand Access to Genetic Diagnosis for Children GeneDx , a leader in rare disease diagnosis and genomic data, has announced the launch of a new digital offering designed to make exome testing more…
BioVigil Surpasses 1 Billion Hand Hygiene Opportunities, Highlighting Continued Focus on Infection Prevention and Patient Safety BioVigil, a leading provider of automated hand hygiene monitoring and infection prevention technology, has announced that its platform has recorded more than 1 billion…
Innate Pharma and Sobi Partner to Advance Lacutamab into Phase 3 Development for Cutaneous T-Cell Lymphoma Innate Pharma SA and Swedish Orphan Biovitrum AB (publ), widely known as Sobi®, have entered into a strategic partnership designed to accelerate the clinical…
Cerepeut Study in Neuron Identifies Mitochondrial Mechanism Driving Tau-Related Neurodegeneration and Highlights CP-235 as Potential Therapy Cerepeut, Inc., a biotechnology company focused on developing mitochondrial therapeutics for neurodegenerative diseases, has announced the publication of new research in Neuron that identifies…
City of Hope Study Shows Education Program Can Dramatically Improve Skin Cancer Screening Among Hematopoietic Cell Transplant Survivors Experts at City of Hope®, one of the nation’s leading cancer research and treatment organizations, are highlighting the importance of skin cancer…
ZAP Surgical Expands Presence in China with New ZAP-X Radiosurgery Installation at Changchun Tumor Hospital ZAP Surgical Systems, Inc., a global innovator in non-invasive robotic brain surgery technologies, has announced the installation of its advanced ZAP-X® Gyroscopic Radiosurgery® platform at…
Niagen Bioscience Partners with Evotec to Advance NB4168 Development for Rare Genetic Disease Niagen Bioscience, Inc. (NASDAQ: NAGE), a biotechnology company recognized for its leadership in NAD+ (nicotinamide adenine dinucleotide) science and healthy aging research, has announced a strategic collaboration…